Dry-AMD High-Throughput Model
Dry Age-related Macular Degeneration
Research/Preclinical ToolsActive
Key Facts
Indication
Dry Age-related Macular Degeneration
Phase
Research/Preclinical Tools
Status
Active
Company
About Axol Bioscience
Axol Bioscience is a leading provider of human iPSC-derived cells and contract services, operating as a critical enabler for drug discovery in human disease modeling. With over a decade of expertise, the company manufactures functional cells like cardiomyocytes and neurons and offers services including custom cell production, disease model creation, reprogramming, and gene editing. It holds ISO 9001:2015 certification for manufacturing and serves a global clientele, positioning itself at the intersection of the growing iPSC tools and services market. The company is privately held and appears to be in a revenue-generating stage, supported by its portfolio of products and collaborative projects.
View full company profileTherapeutic Areas
Other Dry Age-related Macular Degeneration Drugs
| Drug | Company | Phase |
|---|---|---|
| elamipretide (ophthalmic) | Stealth BioTherapeutics | Phase 3 |
| Lead Dry AMD Program | Perceive Biotherapeutics | Preclinical |
| Undisclosed PolyCol program | Stuart Therapeutics | Pre-clinical |